1-3 of 3
Trevor F. Carr
Close
Sort by
Journal Articles

Does the Use of Different Factor VIII Products Influence Inhibitor Formation in Patients with Haemaphilia A.

David E. Howarth, MB, ChB, MRCP, Jayne L. Kennedy, Andrew M. Will, FRCP, FRCPath, MD, Trevor F. Carr, PhD, Wynn Robert, BA, MRCP, FRCPath, M.
Journal: Blood
Blood (2005) 106 (11): 4029.
https://doi.org/10.1182/blood.V106.11.4029.4029
Published: 2005
Journal Articles

Success of Adoptive Immunotherapy Followed by Stem Cell Transplantation in the Management of Epstein Barr Virus (EBV)-Driven Primary Central Nervous System Lymphoma (PCNSL) in Immunodeficient Child.

Maged I. Gharib, MD, MRCP, MRCPath, Tanzina Haque, MB.BS, PhD, MRCPath, James A. Nicholson, MB.BS, MRCP, Gwen Wilkie, BSc., Marie Morton-Jones, BSc, Trevor F. Carr, PhD, Peter D. Arkwright, MB, D. Phil, Andrew J.L. Turner, MB.ChB, FRCPath, Anna M. Kelsey, FRCPath, Dorothy H. Crawford, MD, PhD, DSc, Robert F. Wynn, MD, MRCP, MRCPath
Journal: Blood
Blood (2004) 104 (11): 3115.
https://doi.org/10.1182/blood.V104.11.3115.3115
Published: 2004
Journal Articles

Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I

Brief Report
Melissa A. Baxter, Robert F. Wynn, Jonathan A. Deakin, Ilaria Bellantuono, Kirsten G. Edington, Alan Cooper, Guy T. N. Besley, Heather J. Church, J. Ed Wraith, Trevor F. Carr, Leslie J. Fairbairn
Journal: Blood
Blood (2002) 99 (5): 1857–1859.
https://doi.org/10.1182/blood.V99.5.1857
Published: 2002